Litcius/Paper detail

Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial

David Erlinge, Jonas Andersson, Ole Fröbert, Mattias Törnerud, Mehmet Hamid, Thomas Kellerth, Per Grimfjärd, Oscar Winnberg, Juliane Jurga, Henrik Wagner, Sammy Zwackman, Martin Adielsson, Patrik Alström, Elli Masoe, Anders Ulvenstam, Jonas Millgård, Felix Böhm, Claes Held, Henrik Renlund, Jonas Oldgren, Pieter C Smits, Candace Elek, Andrea Abizaid, Stefan James

2024The Lancet30 citationsDOI

Topics & Concepts

MedicinePercutaneous coronary interventionDrug-eluting stentRandomized controlled trialStentPercutaneousImplantPsychological interventionSurgeryInternal medicineMyocardial infarctionPsychiatryCoronary Interventions and DiagnosticsCoronary Artery AnomaliesCardiac Imaging and Diagnostics
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial | Litcius